Grants and Contributions:
Title:
Recombinant Antibody Optimization
Agreement Number:
924645
Agreement Value:
$45,000.00
Agreement Date:
Mar 11, 2019 - Jul 31, 2020
Description:
This project entails production and purification of monoclonal antibodies which will be used for the development of diagnostics.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R3Y 0A2
Reference Number:
172-2018-2019-Q4-924645
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
810234633
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 157 days.
Amendment Date
Mar 27, 2020
Recipient's Legal Name:
Vastcon Inc.
Federal Riding Name:
Winnipeg South
Federal Riding Number:
46013
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911
Amendments: